v3.24.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2024
Jul. 16, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Trading Symbol ALV  
Security Exchange Name NYSE  
Entity Registrant Name AUTOLIV, INC.  
Entity Central Index Key 0001034670  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Title of 12(b) Security Common Stock (par value $1.00 per share)  
Entity Common Stock, Shares Outstanding   80,079,757
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity File Number 001-12933  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 51-0378542  
Entity Address, Address Line One Klarabergsviadukten 70, Section B7  
Entity Address, Address Line Two Box 70381  
Entity Address, City or Town Stockholm  
Entity Address, Country SE  
Entity Address, Postal Zip Code SE-107 24  
City Area Code +46 8  
Local Phone Number 587 20 600  
Document Quarterly Report true  
Document Transition Report false  
v3.24.2
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Net sales $ 2,605 $ 2,635 $ 5,220 $ 5,127
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Cost of sales $ (2,130) $ (2,188) $ (4,303) $ (4,301)
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Gross profit $ 475 $ 447 $ 917 $ 826
Selling, general and administrative expenses (138) (130) (270) (262)
Research, development and engineering expenses, net (116) (120) (229) (237)
Other income (expense), net1) (14) (103) (18) (107)
Operating income 206 94 400 221
Income from equity method investment 2 1 3 2
Interest income 3 6 7 8
Interest expense (28) (25) (54) (45)
Other non-operating items, net 1 7 0 5
Income before income taxes 183 83 356 191
Income tax expense (44) (30) (91) (64)
Net income [1] 139 53 266 127
Less: Net income attributable to non-controlling interest 0 0 1 1
Net income attributable to controlling interest $ 138 $ 53 $ 265 $ 127
Net earnings per share - basic $ 1.71 $ 0.61 $ 3.24 $ 1.48
Net earnings per share - diluted $ 1.71 $ 0.61 $ 3.23 $ 1.47
Basic: Weighted average common stock 80.9 85.6 81.6 85.9
Weighted average number of shares outstanding, assuming dilution and net of treasury shares (in millions) 81.1 85.8 82.1 86.0
Cash dividend per share - declared $ 0.68 $ 0.66 $ 1.36 $ 1.32
Cash dividend per share – paid $ 0.68 $ 0.66 $ 1.36 $ 1.32
[1] For the three months periods ended June 30, 2024 and 2023, the aggregate transaction gain (loss) included in net income for the period were a gain of $4 million and a loss of $10 million, respectively. For the six months periods ended June 30, 2024 and 2023, the aggregate transaction gain (loss) included in net income for the period were a loss of $2 million and a loss of $15 million, respectively.
v3.24.2
CONSOLIDATED STATEMENTS OF INCOME (Parenthetical) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Gain (loss) on aggregate transactions $ 4 $ (10) $ (2) $ (15)
v3.24.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net income [1] $ 139 $ 53 $ 266 $ 127
Other comprehensive income (loss) before tax:        
Change in cumulative translation adjustments (59) (46) (105) (10)
Net change in unrealized components of defined benefit plans 3 5 9 5
Other comprehensive (loss), before tax (56) (40) (96) (5)
Tax effect allocated to other comprehensive income (loss) (1) (1) (2) (1)
Other comprehensive (loss), net of tax (56) (41) (98) (6)
Comprehensive income 83 12 168 122
Less: Comprehensive income (loss) attributable to non-controlling interest 0 0 0 0
Comprehensive income attributable to controlling interest $ 82 $ 12 $ 167 $ 121
[1] For the three months periods ended June 30, 2024 and 2023, the aggregate transaction gain (loss) included in net income for the period were a gain of $4 million and a loss of $10 million, respectively. For the six months periods ended June 30, 2024 and 2023, the aggregate transaction gain (loss) included in net income for the period were a loss of $2 million and a loss of $15 million, respectively.
v3.24.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 408 $ 498
Receivables, net 2,090 2,198
Inventories, net 936 1,012
Prepaid expenses and accrued income 193 173
Other current assets 76 93
Total current assets 3,703 3,974
Property, plant and equipment, net 2,197 2,192
Operating lease right-of-use assets 167 176
Goodwill and intangible assets, net 1,379 1,385
Other non-current assets 564 606
Total assets 8,010 8,332
Liabilities and equity    
Short-term debt [1] 455 538
Accounts payable [2] 1,858 1,978
Accrued expenses 1,120 1,135
Operating lease liabilities - current 41 39
Other current liabilities 312 345
Total current liabilities 3,785 4,035
Long-term debt [1] 1,540 1,324
Pension liability 140 159
Operating lease liabilities - non-current 127 135
Other non-current liabilities 106 109
Total non-current liabilities 1,913 1,728
Common stock 85 88
Additional paid-in capital 993 1,044
Retained earnings 2,174 2,289
Accumulated other comprehensive loss [3] (593) (496)
Treasury stock (360) (368)
Total controlling interest's equity 2,298 2,557
Non-controlling interest 13 13
Total equity 2,311 2,570
Total liabilities and equity $ 8,010 $ 8,332
[1] Debt as reported in balance sheet.
[2] Amount of obligations confirmed under the Company's Supplier Finance Program that remains unpaid is reported as Accounts Payable in the Condensed Consolidated Balance Sheets. Amount of obligations outstanding as of June 30, 2024 and December 31, 2023 are $335 million and $333 million, respectively.
[3] Including cumulative translation adjustment as of June 30, 2024 and December 31, 2023 to the amount of $(554) million and $(449) million, respectively.
v3.24.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Company's Supplier Finance Program $ 335 $ 333
Cumulative translation adjustment $ (554) $ (449)
v3.24.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net income [1] $ 266 $ 127
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 192 186
Other, net (9) (8)
Net change in operating assets and liabilities 14 28
Net cash provided by operating activities 462 334
Investing activities    
Expenditures for property, plant and equipment (294) (268)
Proceeds from sale of property, plant and equipment 8 1
Net cash used in investing activities (286) (267)
Financing activities    
Net (decrease) increase in short-term debt (67) 5
Proceeds from long-term debt 534 556
Repayment of long-term debt (306) (533)
Dividends paid (111) (113)
Stock repurchased (320) (82)
Common stock options exercised 0 0
Dividend paid to non-controlling interest (1) (1)
Net cash used in financing activities (269) (168)
Effect of exchange rate changes on cash and cash equivalents 3 (17)
Net decrease in cash and cash equivalents (90) (119)
Cash and cash equivalents at beginning of period 498 594
Cash and cash equivalents at end of period $ 408 $ 475
[1] For the three months periods ended June 30, 2024 and 2023, the aggregate transaction gain (loss) included in net income for the period were a gain of $4 million and a loss of $10 million, respectively. For the six months periods ended June 30, 2024 and 2023, the aggregate transaction gain (loss) included in net income for the period were a loss of $2 million and a loss of $15 million, respectively.
v3.24.2
CONSOLIDATED STATEMENTS OF TOTAL EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Treasury stock
Total controlling interest's equity
Non-controlling interest
Balance at Dec. 31, 2022 $ 2,626 $ 91 $ 1,113 $ 2,310 $ (522) $ (379) $ 2,613 $ 13
Comprehensive Loss:                
Net income 74     74     74 0
Foreign currency translation adjustment (36)       36   36 0
Pension liability 0       0   0  
Comprehensive income 110     74 35   110 0
Retired and repurchased shared (42) 0 (9) (33)     (42)  
Stock-based compensation 3         3 3  
Cash dividends declared (57)     (57)     (57)  
Balance at Mar. 31, 2023 2,641 91 1,105 2,295 (487) (376) 2,627 14
Balance at Dec. 31, 2022 2,626 91 1,113 2,310 (522) (379) 2,613 13
Comprehensive Loss:                
Net income [1] 127              
Comprehensive income 122              
Balance at Jun. 30, 2023 2,557 90 1,096 2,260 (527) (374) 2,545 13
Balance at Mar. 31, 2023 2,641 91 1,105 2,295 (487) (376) 2,627 14
Comprehensive Loss:                
Net income 53 [1]     53     53 0
Foreign currency translation adjustment (46)       (45)   (45) (1)
Pension liability 4       4   4  
Comprehensive income 12     53 (41)   12 0
Retired and repurchased shared (41) 0 (9) (31)     (41)  
Stock-based compensation 3         3 3  
Dividends paid to non-controlling interest on subsidiary shares (1)           0 (1)
Cash dividends declared (56)     (56)     (56)  
Balance at Jun. 30, 2023 2,557 90 1,096 2,260 (527) (374) 2,545 13
Balance at Dec. 31, 2023 2,570 88 1,044 2,289 (496) (368) 2,557 13
Comprehensive Loss:                
Net income 127     126     126  
Foreign currency translation adjustment (47)       (46)   (46) 0
Pension liability 5       5   5  
Comprehensive income 85     126 (41)   85 0
Retired and repurchased shared (161) (1) (26) (134)     (161)  
Stock-based compensation 4         4 4  
Cash dividends declared (56)     (56)     (56)  
Balance at Mar. 31, 2024 2,442 86 1,018 2,226 (537) (364) 2,429 13
Balance at Dec. 31, 2023 2,570 88 1,044 2,289 (496) (368) 2,557 13
Comprehensive Loss:                
Net income [1] 266              
Comprehensive income 168              
Balance at Jun. 30, 2024 2,311 85 993 2,174 (593) (360) 2,298 13
Balance at Mar. 31, 2024 2,442 86 1,018 2,226 (537) (364) 2,429 13
Comprehensive Loss:                
Net income 139 [1]     138     138 0
Foreign currency translation adjustment (59)       (59)   (59) 0
Pension liability 2       2   2  
Comprehensive income 83     138 (56)   82 0
Retired and repurchased shared (162) (1) (25) (136)     (162)  
Stock-based compensation 4         4 4  
Dividends paid to non-controlling interest on subsidiary shares (1)           0 (1)
Cash dividends declared (55)     (55)     (55)  
Balance at Jun. 30, 2024 $ 2,311 $ 85 $ 993 $ 2,174 $ (593) $ (360) $ 2,298 $ 13
[1] For the three months periods ended June 30, 2024 and 2023, the aggregate transaction gain (loss) included in net income for the period were a gain of $4 million and a loss of $10 million, respectively. For the six months periods ended June 30, 2024 and 2023, the aggregate transaction gain (loss) included in net income for the period were a loss of $2 million and a loss of $15 million, respectively.
v3.24.2
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ 138 $ 53 $ 265 $ 127
v3.24.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.2
Basis of Presentation
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Basis of Presentation

1. BASIS OF PRESENTATION

The accompanying interim unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements. The unaudited condensed consolidated financial statements have been prepared on the same basis as the prior year audited consolidated financial statements and all adjustments considered necessary for a fair presentation have been included in the consolidated financial statements. All such adjustments are of a normal recurring nature. The results for the interim period are not necessarily indicative of the results to be expected for any future period or for the fiscal year ending December 31, 2024.

The Condensed Consolidated Balance Sheet as of December 31, 2023 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by U.S. GAAP for complete consolidated financial statements.

The Company has one reportable segment, which includes Autoliv’s airbag and seatbelt products and components.

Certain amounts in the condensed consolidated financial statements and associated notes may not reconcile due to rounding. All percentages have been calculated using unrounded amounts. Certain amounts in prior periods have been reclassified to conform to current year presentation.

Statements in this report that are not of historical fact are forward-looking statements that involve risks and uncertainties that could affect the actual results of the Company. A description of the important factors that could cause Autoliv’s actual results to differ materially from the forward-looking statements contained in this report may be found in this report and Autoliv’s other reports filed with the Securities and Exchange Commission (the “SEC”). For further information, refer to the consolidated financial statements, footnotes and definitions thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 20, 2024.

v3.24.2
New Accounting Standards
6 Months Ended
Jun. 30, 2024
Accounting Changes and Error Corrections [Abstract]  
New Accounting Standards

2. NEW ACCOUNTING STANDARDS

Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB’s Accounting Standards Codification (“ASC”).

 

Adoption of new accounting standards

None.

Accounting standards issued but not yet adopted

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures, which improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this update require that a public entity make additional disclosures related to segments if it has them. A public entity that has a single reportable segment would be required to provide all the disclosures required by the amendments in this update and all existing segment disclosures in Topic 280. The amendments in this update are affective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments in this update should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently assessing the impact that ASU 2023-07 will have on its financial statements and will adopt the amendments in this update upon the effective date.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures as well as improve the effectiveness of income tax disclosures. The amendments in this update require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. The amendments in this update also require that all entities disclose on an annual basis certain detailed information about income taxes paid. The amendments in this update related to the rate reconciliation and income taxes paid disclosures improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. The amendments allow investors to better assess, in their capital allocation decisions, how an entity’s worldwide operations and related tax risks and tax planning and operational opportunities affect its income tax rate and prospects for future cash flows. The amendments in this update are affective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments in this update should be applied on a prospective basis. Retrospective application is permitted. The Company is currently assessing the impact that ASU 2023-09 will have on its financial statements and will adopt the amendments in this update prospectively upon the effective date.

In March 2024, the SEC adopted final rules requiring registrants to disclose climate-related information in their annual reports. The final rules require information about a registrant’s climate-related risks that have materially impacted, or are reasonably likely to have a material impact on, its business strategy, results of operations, or financial condition. In addition, under the final rules, certain disclosures related to severe weather events and other natural conditions will be required in a registrant’s audited financial statements. The new requirements are required on a prospective basis and a phased-in compliance period becomes effective for the Company beginning with its Annual Report on Form 10-K for the year ending December 31, 2025. However, pending the resolution of legal challenges that were subsequently filed against these rules, in April 2024, the SEC stayed the effectiveness of the rules. Therefore, the disclosure requirements of these rules and the timing of their effectiveness is uncertain. The Company is currently assessing the anticipated impact that the rules will have on its financial statements if and when effective and will implement disclosures upon any such effective dates.

v3.24.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements

3. FAIR VALUE MEASUREMENTS

Assets and liabilities measured at fair value on a recurring basis

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and other current financial assets and liabilities approximate their fair value because of the short-term maturity of these instruments.

The Company uses derivative financial instruments (“derivatives”) as part of its debt management to mitigate the market risk that occurs from its exposure to changes in interest rates and foreign exchange rates. The Company does not enter into derivatives for trading or other speculative purposes. The Company’s use of derivatives is in accordance with the strategies contained in the Company’s overall financial policy. All derivatives are recognized in the consolidated financial statements at fair value. For certain derivatives, hedge accounting is not applied either because non-hedge accounting treatment creates the same accounting result or the hedge does not meet the hedge accounting requirements, although each hedge is entered into applying the same rationale concerning mitigating market risk that occurs from changes in interest rates and foreign exchange rates.

The degree of judgment utilized in measuring the fair value of the instruments generally correlates to the level of pricing observability. Pricing observability is impacted by several factors, including the type of asset or liability, whether the asset or liability has an established market and the characteristics specific to the transaction. Instruments with readily active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of pricing observability and a lesser degree of judgment utilized in measuring fair value. Conversely, assets rarely traded or not quoted will generally have less, or no, pricing observability and a higher degree of judgment utilized in measuring fair value.

All the Company’s derivatives are classified as Level 2 financial instruments in the fair value hierarchy. Level 2 pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reported date. The nature of these assets and liabilities include items for which quoted prices are available but traded less frequently, and items that are fair valued using other financial instruments, the parameters of which can be directly observed.

The carrying value is the same as the fair value as these instruments are recognized in the consolidated financial statements at fair value. Although the Company is party to close-out netting agreements (“ISDA agreements”) with all of its derivative counterparties, the fair values in the tables below and in the Condensed Consolidated Balance Sheets as of June 30, 2024 and December 31, 2023 have been presented on a gross basis. According to the ISDA agreements, transaction amounts payable to a counterparty on the same date and in the same currency can be netted. The amounts subject to netting agreements that the Company chose not to offset are presented below.

Derivatives designated as hedging instruments

There were no derivatives designated as hedging instruments as of June 30, 2024 or December 31, 2023 related to the Company's operations.

 

Derivatives not designated as hedging instruments

Derivatives not designated as hedging instruments relate to economic hedges and are marked to market with all amounts recognized in the Consolidated Statements of Income. The derivatives not designated as hedging instruments outstanding as of June 30, 2024 and December 31, 2023 were foreign exchange swaps.

For the three months periods ended June 30, 2024 and 2023, the gains (losses) recognized in other non-operating items, net were a loss of $1 million and a gain of $13 million, respectively, for derivative instruments not designated as hedging instruments. For the six months periods ended June 30, 2024 and 2023, the gains (losses) recognized in other non-operating items, net were a gain of $10 million and a gain of $8 million, respectively. The realized part of the losses referred to above is reported under financing activities in the statement of cash flows.

For the three and six months periods ended June 30, 2024, the gains (losses) recognized as interest expense were a gain of $1 million and a gain of $2 million, respectively. For the three and six months periods ended June 30, 2023, the gains (losses) recognized as interest expense were immaterial.

The tables below present information about the Company’s derivative financial assets and liabilities measured at fair value on a recurring basis (dollars in millions).

 

 

 

As of

 

 

 

 

June 30, 2024

 

 

 

December 31, 2023

 

 

 

 

 

 

 

Fair Value Measurements

 

 

 

 

 

 

Fair Value Measurements

 

 

Description

 

Nominal
volume

 

 

Derivative
asset
(Other
current assets)

 

 

Derivative
liability
(Other
current
liabilities)

 

 

 

Nominal
volume

 

 

Derivative
asset
(Other
current assets)

 

 

Derivative
liability
(Other
current
liabilities)

 

 

Derivatives not designated as hedging
   instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange swaps, less
   than 6 months

 

$

2,166

 

1)

$

11

 

2)

$

15

 

3)

 

$

1,895

 

4)

$

22

 

5)

$

12

 

6)

Total derivatives not designated
   as hedging instruments

 

$

2,166

 

 

$

11

 

 

$

15

 

 

 

$

1,895

 

 

$

22

 

 

$

12

 

 

1) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $2,166 million.

2) Net amount after deducting for offsetting swaps under ISDA agreements is $11 million.

3) Net amount after deducting for offsetting swaps under ISDA agreements is $15 million.

4) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,895 million.

5) Net amount after deducting for offsetting swaps under ISDA agreements is $22 million.

6) Net amount after deducting for offsetting swaps under ISDA agreements is $12 million.

 

 

Fair Value of Debt

The fair value of long-term debt is determined either from quoted market prices as provided by participants in the secondary market or for long-term debt without quoted market prices, estimated using a discounted cash flow method based on the Company’s current borrowing rates for similar types of financing. The Company has determined that each of these fair value measurements of debt reside within Level 2 of the fair value hierarchy.

 

In February 2024, the Company issued 5.5-year notes for a total of €500 million in the Eurobond market. The notes carry a coupon of 3.625% and mature in August 2029. In April 2024, the Company repaid $297 million of US Private Placement debt.

The fair value and carrying value of debt is summarized in the table below (dollars in millions).

 

 

 

As of

 

 

 

June 30, 2024

 

 

December 31, 2023

 

 

 

Carrying
value
1)

 

 

Fair
value

 

 

Carrying
value
1)

 

 

Fair
value

 

Long-term debt

 

 

 

 

 

 

 

 

 

 

 

 

Bonds

 

$

1,540

 

 

$

1,525

 

 

$

1,023

 

 

$

1,022

 

Loans

 

 

 

 

 

 

 

 

301

 

 

 

306

 

Total long-term debt

 

 

1,540

 

 

 

1,525

 

 

 

1,324

 

 

 

1,328

 

 

 

 

 

 

 

 

 

 

 

 

 

Short-term debt

 

 

 

 

 

 

 

 

 

 

 

 

Short-term portion of long-term debt

 

 

282

 

 

 

285

 

 

 

297

 

 

 

297

 

Overdrafts and other short-term debt

 

 

174

 

 

 

174

 

 

 

241

 

 

 

241

 

Total short-term debt

 

$

455

 

 

$

459

 

 

$

538

 

 

$

538

 

1) Debt as reported in balance sheet.

Assets and liabilities measured at fair value on a non-recurring basis

In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company also has assets and liabilities in its balance sheet that are measured at fair value on a nonrecurring basis, including certain long-lived assets, including equity method investments, goodwill and other intangible assets, typically as it relates to impairment.

The Company has determined that the fair value measurements included in each of these assets and liabilities rely primarily on Company-specific inputs and the Company’s assumptions about the use of the assets and settlements of liabilities, as observable inputs are not available. The Company has determined that each of these fair value measurements reside within Level 3 of the fair value hierarchy. To determine the fair value of long-lived assets, the Company utilizes the projected cash flows expected to be generated by the long-lived assets, then discounts the future cash flows over the expected life of the long-lived assets.

For the three and six months periods ended June 30, 2024 and June 30, 2023, the Company did not record any material impairment charges on its long-lived assets for its operations.

v3.24.2
Income Taxes
6 Months Ended
Jun. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

4. INCOME TAXES

The effective tax rate for the three months period ended June 30, 2024 was 24.1% compared to 35.8% for the three months period ended June 30, 2023. Discrete tax items, net for the three months period ended June 30, 2024 had a favorable impact of 4.9%. Discrete tax items, net for the three months period ended June 30, 2023 had a favorable impact of 4.5%.

The effective tax rate for the six months period ended June 30, 2024 was 25.5% compared to 33.4% for the six months period ended June 30, 2023. Discrete tax items, net for the six months period ended June 30, 2024 had a favorable impact of 3.7%. Discrete tax items, net for the six months period ended June 30, 2023 had a favorable impact of 1.5%.

The Company files income tax returns in the U.S. federal jurisdiction, various U.S. states, and non-U.S. jurisdictions. At any given time, the Company is undergoing tax audits in several tax jurisdictions covering multiple years. The Company is no longer subject to income tax examination by the U.S. federal income tax authorities for years prior to 2015. With few exceptions, the Company is no longer subject to income tax examination by U.S. state or local tax authorities or by non-U.S. tax authorities for years before 2012.

As of June 30, 2024, the Company is not aware of any proposed income tax adjustments resulting from tax examinations that would have a material impact on the Company’s condensed consolidated financial statements. The conclusion of such audits could result in additional increases or decreases to unrecognized tax benefits in some future period or periods.

During the six months period ended June 30, 2024, the Company recorded a net increase of $4 million to income tax reserves for unrecognized tax benefits based on tax positions related to the current year, including accruing additional interest related to unrecognized tax benefits from prior years. In addition, during the six month period ended June 30, 2024, the Company recorded a net decrease of $14 million to income tax reserves for unrecognized tax benefits based on tax positions taken in prior years, mainly due to conclusion of tax audits and expiration of the statute of limitations in various jurisdictions.

Of the total unrecognized tax benefits of $53 million recorded as of June 30, 2024, $16 million is classified as current tax payable within Other current liabilities and $37 million is classified as non-current tax payable within Other non-current liabilities on the Condensed Consolidated Balance Sheet.

v3.24.2
Inventories
6 Months Ended
Jun. 30, 2024
Inventory Disclosure [Abstract]  
Inventories

5. INVENTORIES

Inventories are stated at the lower of cost (“FIFO”) and net realizable value. The components of inventories were as follows (dollars in millions):

 

 

 

As of

 

 

 

June 30, 2024

 

 

December 31, 2023

 

Raw materials

 

$

422

 

 

$

457

 

Work in progress

 

 

324

 

 

 

347

 

Finished products

 

 

277

 

 

 

296

 

Inventories

 

 

1,023

 

 

 

1,100

 

Inventory valuation reserve

 

 

(87

)

 

 

(89

)

Total inventories, net of reserve

 

$

936

 

 

$

1,012

 

v3.24.2
Restructuring
6 Months Ended
Jun. 30, 2024
Restructuring and Related Activities [Abstract]  
Restructuring

6. RESTRUCTURING

As of June 30, 2024, the majority of the restructuring reserve balance of $189 million is attributed to global structural cost reduction program activities initiated in Europe in 2023. These activities are expected to be concluded during 2024 and 2025.

Provisions and cash payments for the three and six months periods ended June 30, 2024 relate to the restructuring activities in Europe. The provision charges for the three and six months periods ended June 30, 2023 mainly relate to restructuring activities in Germany and UK.

The table below summarizes the change in the balance sheet position of the employee-related restructuring reserves (dollars in millions). The restructuring reserve balances are included within Accrued expenses in the Condensed Consolidated Balance Sheets. The changes in the employee-related reserves have been charged against Other income (expense), net in the Consolidated Statements of Income. Restructuring costs other than employee related costs are immaterial for all periods presented.

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Reserve at beginning of the period

 

$

193

 

 

$

29

 

 

$

213

 

 

$

32

 

Provision - charge

 

 

13

 

 

 

107

 

 

 

14

 

 

 

110

 

Provision - reversal

 

 

(0

)

 

 

(0

)

 

 

(0

)

 

 

(0

)

Cash payments

 

 

(15

)

 

 

(9

)

 

 

(30

)

 

 

(15

)

Translation difference

 

 

(1

)

 

 

(0

)

 

 

(7

)

 

 

0

 

Reserve at end of the period

 

$

189

 

 

$

127

 

 

$

189

 

 

$

127

 

v3.24.2
Product-Related Liabilities
6 Months Ended
Jun. 30, 2024
Product Warranties Disclosures [Abstract]  
Product-Related Liabilities

7. PRODUCT-RELATED LIABILITIES

The Company is exposed to product liability and warranty claims in the event that the Company’s products fail to perform as represented and such failure results, or is alleged to result, in bodily injury, and/or property damage or other loss. The Company has reserves for product risks. Such reserves are related to product performance issues, including recalls, product liability, and warranty issues. For further explanation, see Note 9. Contingent Liabilities below.

For the three months period ended June 30, 2024, cash payments mainly relate to warranty related issues. For the six months period ended June 30, 2024, provision reversals and cash payments primarily relate to recall related issues. For the three and six months periods ended June 30, 2023, provisions and cash payments primarily related to warranty related issues. As of June 30, 2024, the reserve for product related liabilities mainly relates to recall related issues.

The table below summarizes the change in the balance sheet position of the product-related liabilities (dollars in millions). The reserve for product related liabilities is included in accrued expenses and other non-current liabilities on the Condensed Consolidated Balance Sheets. A majority of the Company’s product-related liabilities as of June 30, 2024 are covered by insurance. Insurance receivables are included within other current assets and other non-current assets on the Condensed Consolidated Balance Sheets. As of June 30, 2024, the Company had total insurance receivables of $57 million.

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Reserve at beginning of the period

 

$

78

 

 

$

141

 

 

$

96

 

 

$

145

 

Change in reserve

 

 

(1

)

 

 

42

 

 

 

(8

)

 

 

43

 

Cash payments

 

 

(4

)

 

 

(4

)

 

 

(14

)

 

 

(9

)

Translation difference

 

 

(0

)

 

 

(0

)

 

 

(1

)

 

 

(0

)

Reserve at end of the period

 

$

73

 

 

$

178

 

 

$

73

 

 

$

178

 

v3.24.2
Retirement Plans
6 Months Ended
Jun. 30, 2024
Retirement Benefits [Abstract]  
Retirement Plans

8. RETIREMENT PLANS

The components of total Net Periodic Benefit Cost associated with the Company’s defined benefit retirement plans are as follows (dollars in millions):

 

U.S. Plans

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Interest cost

 

$

3

 

 

$

3

 

 

$

6

 

 

$

6

 

Expected return on plan assets

 

 

(3

)

 

 

(3

)

 

 

(6

)

 

 

(5

)

Settlement loss

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Net periodic benefit (gain) cost

 

$

(0

)

 

$

0

 

 

$

(0

)

 

$

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-U.S. Plans

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Service cost

 

$

2

 

 

$

3

 

 

$

5

 

 

$

5

 

Interest cost

 

 

3

 

 

 

3

 

 

 

6

 

 

 

5

 

Expected return on plan assets

 

 

(1

)

 

 

(0

)

 

 

(2

)

 

 

(1

)

Amortization of actuarial loss

 

 

0

 

 

 

0

 

 

 

1

 

 

 

0

 

Net periodic benefit cost

 

$

5

 

 

$

6

 

 

$

9

 

 

$

9

 

 

The Service cost component in the table above is reported among other employee compensation costs in the Consolidated Statements of Income. The remaining components - Interest cost, Expected return on plan assets, Amortization of actuarial loss, Settlement loss (gain) and Curtailment gain - are reported as Other non-operating items, net in the Consolidated Statements of Income.

 

The Company triggered settlement accounting for the primary U.S. pension plan in the second quarter of 2024 because the lump-sum payments made during the quarter exceeded the sum of Service cost and Interest cost for this U.S. plan. Due to the settlement accounting, the obligation and plan assets for the primary U.S. plan have been re-measured as of June 30, 2024, which resulted in an immaterial change in the net pension liability compared to December 31, 2023. The discount rate used to determine the U.S. net periodic benefit cost because of the re-measurement was changed from 5.35% to 5.57% in the second quarter of 2024. The expected long-term rate of return on plan asset is unchanged at 6.21%.

v3.24.2
Contingent Liabilities
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Contingent Liabilities

9. CONTINGENT LIABILITIES

Legal Proceedings

Various claims, lawsuits, and proceedings are pending or threatened against the Company or its subsidiaries, covering a range of matters that arise in the ordinary course of its business activities with respect to commercial, product liability, and other matters. Litigation is subject to many uncertainties, and the outcome of any litigation cannot be assured. After discussions with counsel, and with the exception of potential future losses resulting from the antitrust proceedings described below, it is the opinion of management that the various legal proceedings and investigations to which the Company currently is a party will not have a material adverse impact on the consolidated financial position of Autoliv, but the Company cannot provide assurance that Autoliv will not experience material litigation, product liability, or other losses in the future.

ANTITRUST MATTERS

Authorities in several jurisdictions have conducted broad, and in some cases, long-running investigations of suspected anti-competitive behavior among parts suppliers in the global automotive vehicle industry. These investigations included, but are not limited to, the products that the Company sells. In addition to concluded matters, authorities of other countries with significant light vehicle manufacturing or sales may initiate similar investigations. As a result of the outcome of the European Commission investigation of anti-competitive behavior among suppliers of occupant safety systems that the Company resolved in 2019 (the "EC investigation"), the Company is subject to multiple subsequent civil disputes with non-governmental third parties stemming from the same facts and circumstances underlying the EC investigation. These disputes could result in significant expenses as well as unfavorable outcomes that could have a material adverse impact on our customer relationships, business prospects, reputation, operating results, cash flows or financial condition, and our insurance would likely not mitigate such impact. The Company cannot predict the duration, scope, or ultimate outcome of any such disputes and is unable to estimate the loss or a range of loss, or predict the reporting periods in which any such loss may be recorded.

PRODUCT WARRANTY, RECALLS AND INTELLECTUAL PROPERTY

Autoliv is exposed to various claims for damages and compensation if its products fail to perform as expected. Such claims can be made, and result in costs and other losses to the Company, even where the product is eventually found to have functioned properly. Where a product (actually or allegedly) fails to perform as expected or is defective, the Company may face warranty and recall claims. Where such (actual or alleged) failure or defect results, or is alleged to result, in bodily injury and/or property damage, the Company may also face product liability and other claims. There can be no assurance that the Company will not experience material warranty, recall or product (or other) liability claims or losses in the future, or that the Company will not incur significant costs to defend against such claims. The Company may be required to participate in a recall involving its products. Each vehicle manufacturer has its own practices regarding product recalls and other product liability actions relating to its suppliers. As suppliers become more integrally involved in the vehicle design process and assume more of the vehicle assembly functions, vehicle manufacturers are increasingly looking to their suppliers for contribution when faced with recalls and product liability claims. Government safety regulators may also play a role in warranty and recall practices. Recall decisions regarding the Company’s products may require a significant amount of judgment by us, our customers and safety regulators and are influenced by a variety of factors. Once a recall has been made, the cost of a recall is also subject to a significant amount of judgment and discussions between the Company and its customers. A warranty, recall or product-liability claim brought against the Company in excess of its insurance may have a material adverse effect on the Company’s business. Vehicle manufacturers are also increasingly requiring their outside suppliers to guarantee or warrant their products and bear the costs of repair and replacement of such products under new vehicle warranties. A vehicle manufacturer may attempt to hold the Company responsible for some, or all, of the repair or replacement costs of products when the product supplied did not perform as represented by us or expected by the customer in either a warranty or a recall situation. Accordingly, the future costs of warranty or recall claims by the customers may be material. However, the Company believes its established reserves are adequate. Autoliv’s warranty reserves are based upon the Company’s best estimates of amounts necessary to settle future and existing claims. The Company regularly evaluates the adequacy of these reserves and adjusts them when appropriate. However, the final amounts actually due related to these matters could differ materially from the Company’s recorded estimates.

In addition, as vehicle manufacturers increasingly use global platforms and procedures, quality performance evaluations are also conducted on a global basis. Any one or more quality, warranty or other recall issue(s) (including those affecting few units and/or having a small financial impact) may cause a vehicle manufacturer to implement measures such as a temporary or prolonged suspension of new orders, which may have a material impact on the Company’s results of operations.

 

The Company maintains a program of insurance, which may include commercial insurance, self-insurance, or a combination of both approaches, for potential recall and product liability claims in amounts and on terms that it believes are reasonable and prudent based on our prior claims experience. The Company’s insurance policies generally include coverage of the costs of a recall, although costs related to replacement parts are generally not covered. In addition, a number of the agreements entered into by the Company, including the Spin-off Agreements, require Autoliv to indemnify the other parties for certain claims. Autoliv cannot assure that the level of coverage will be sufficient to cover every possible claim that can arise in our businesses or with respect to other obligations, now or in the future, or that such coverage always will be available should we, now or in the future, wish to extend, increase or otherwise adjust our insurance.

As noted in Note 7 above, as of June 30, 2024, the Company has accrued $73 million for total product related liabilities. The majority of the total product liability accrual as of June 30, 2024, relates to recalls, which are generally covered by insurance. Insurance receivables for such recall related liabilities total $57 million as of June 30, 2024.

 

Product Liability:

Autoliv and some of its subsidiaries have been named as one of several defendants in a consolidated class action lawsuit in a multi-district litigation (In Re: ARC Airbag Inflators Products Liability Litigation MDL, No. 3051) in the Northern District of Georgia. The plaintiffs in the multi-district litigation (the "ARC Inflator Class Action") brought claims for fraud, breach of warranty, and violations of consumer protection and trade practices stemming from ARC inflators included in airbag modules that Autoliv or its subsidiaries allegedly supplied after Autoliv acquired certain Delphi assets (the “Delphi Acquisition”) in December 2009. The Company denies these allegations. Autoliv is not aware of any performance issues regarding ARC inflators included with its airbags at the directions of its customers that it shipped following the Delphi Acquisition. The proceedings remain ongoing. The Company has determined pursuant to ASC 450 that a loss is reasonably possible with respect to the ARC Inflator Class Action. However, the Company continues to evaluate this matter, no accrual has been made, and no estimated range of potential loss can be determined at this time. The Company cannot predict the ultimate outcome of the ARC Inflator Class Action.

On September 5, 2023, the National Highway Traffic Safety Administration (“NHTSA”) issued an initial decision to recall approximately 52 million frontal driver and passenger airbag inflators manufactured by ARC and Delphi Automotive Systems because NHTSA determined that the airbag inflators contain a safety defect resulting in field ruptures. Some of the ARC inflators included in the airbag modules that Autoliv or its subsidiaries supplied after the Delphi Acquisition were included in such initial decision. NHTSA has yet to release its final decision. If NHTSA's final decision results in a recall, it is anticipated that such decision will be challenged in US federal court. The Company has determined pursuant to ASC 450 that a loss is reasonably possible with respect to the NHTSA ARC recall. However, the Company continues to evaluate this matter, no accrual has been made, and no estimated range of potential loss can be determined at this time. The Company cannot predict the ultimate outcome of the NHTSA ARC recall.

 

Specific Recalls:

In the fourth quarter of 2020, the Company was made aware of a potential recall by American Honda Motor Co. and the recall of approximately 449,000 vehicles relating to the malfunction of front seat belt buckles was announced on March 9, 2023 (the “Honda Buckle Recall”). The Company determined pursuant to ASC 450 that a loss with respect to the Honda Buckle Recall is probable and accrued an amount that is reflected in the total product liability accrual in the fourth quarter of 2020, increased the accrual in the fourth quarter of 2021 and reduced the accrual in the fourth quarter of 2023 based on vehicle repair cost data. Following the accrual reduction in the fourth quarter of 2023, the amount by which the product liability accrual exceeds the product liability insurance receivable with respect to the Honda Buckle Recall is $10 million and includes self-insurance retention costs and deductibles. The ultimate loss to the Company of the Honda Buckle Recall could be materially different from the amount the Company has accrued.

Volvo Car USA, LLC (together with its affiliates, “Volvo”) has recalled approximately 762,000 vehicles relating to the malfunction of inflators produced by ZF (the “ZF Inflator Recall”). The recalled ZF inflators were included in airbag modules supplied by the Company only to Volvo. The recall commenced in November 2020 and later expanded in September 2021. Because the Company’s airbags were involved with the ZF Inflator Recall, the Company has determined pursuant to ASC 450 that a loss is reasonably possible with respect to the ZF Inflator Recall. The Company continues to evaluate this matter with Volvo and ZF and no accrual has been made. Although the Company currently estimates a range of $0 to $43 million with respect to this potential loss, the Company anticipates that any losses net of insurance claims and claims against ZF will be immaterial.

Intellectual Property:

In its products, the Company utilizes technologies which may be subject to intellectual property rights of third parties. While the Company does seek to procure the necessary rights to utilize intellectual property rights associated with its products, it may fail to do so. Where the Company so fails, the Company may be exposed to material claims from the owners of such rights. Where the Company has sold products which infringe upon such rights, its customers may be entitled to be indemnified by the Company for the claims they suffer as a result thereof. Such claims could be material.

The table in Note 7 above summarizes the change in the balance sheet position of the product-related liabilities.

v3.24.2
Stock Incentive Plan
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock Incentive Plan

10. STOCK INCENTIVE PLAN

Eligible employees and non-employee directors of the Company participate in the Autoliv, Inc.1997 Stock Incentive Plan, as amended, (“the Plan”), and receive Autoliv stock-based awards which include restricted stock units (“RSUs”) and performance-based restricted stock units (“PSUs”) and, in the past, included stock options.

For the three and six months periods ended June 30, 2024, the Company recorded approximately $4 million and $8 million, respectively, in stock-based compensation expense related to RSUs and PSUs. For the three and six months periods ended June 30, 2023, the Company recorded approximately $3 million and $8 million, respectively, in stock-based compensation expense related to RSUs and PSUs.

During the three and six months periods ended June 30, 2024, approximately 16 thousand and 117 thousand shares of common stock from the treasury stock were utilized by the Plan. During the three and six months periods ended June 30, 2023, approximately 20 thousand and 112 thousand shares, respectively, of common stock from the treasury stock were utilized by the Plan.

v3.24.2
Earnings per share
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Earnings per share

11. EARNINGS PER SHARE

 

The computation of basic and diluted earnings per share is set forth in the table below. Anti-dilutive shares outstanding were immaterial for all periods presented below.

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(In millions, except per share amounts)

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to controlling interest

 

$

138

 

 

$

53

 

 

$

265

 

 

$

127

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic: Weighted average common stock

 

 

80.9

 

 

 

85.6

 

 

 

81.6

 

 

 

85.9

 

Add: Weighted average stock options/share awards

 

 

0.2

 

 

 

0.1

 

 

 

0.4

 

 

 

0.2

 

Diluted weighted average common stock:

 

 

81.1

 

 

 

85.8

 

 

 

82.1

 

 

 

86.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings per share - basic

 

$

1.71

 

 

$

0.61

 

 

$

3.24

 

 

$

1.48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings per share - diluted

 

$

1.71

 

 

$

0.61

 

 

$

3.23

 

 

$

1.47

 

v3.24.2
Revenue Disaggregation
6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

12. REVENUE DISAGGREGATION

 

The Company’s disaggregated revenue for the three and six months periods ended June 30, 2024 and June 30, 2023 were as follows (dollars in millions).

 

Net Sales by Products

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Airbags, Steering Wheels and Other1)

 

$

1,747

 

 

$

1,757

 

 

$

3,528

 

 

$

3,430

 

Seatbelt Products and Other1)

 

 

858

 

 

 

878

 

 

 

1,692

 

 

 

1,698

 

Total net sales

 

$

2,605

 

 

$

2,635

 

 

$

5,220

 

 

$

5,127

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales by Region

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Americas

 

$

893

 

 

$

916

 

 

$

1,786

 

 

$

1,747

 

Europe

 

 

761

 

 

 

751

 

 

 

1,531

 

 

 

1,476

 

China

 

 

468

 

 

 

497

 

 

 

928

 

 

 

950

 

Asia excl. China

 

 

483

 

 

 

471

 

 

 

975

 

 

 

954

 

Total net sales

 

$

2,605

 

 

$

2,635

 

 

$

5,220

 

 

$

5,127

 

1) Including Corporate sales.

Contract Balances

Contract assets relate to the Company's rights to consideration for work completed but not billed (generally in conjunction with contracts for which revenue is recognized over time) at the reporting date on production parts and is included in Other current assets in the Condensed Consolidated Balance Sheet. The contract assets are reclassified into the receivables balance when the rights to receive payments become unconditional. The net change in the contract assets balance, reflecting the adjustments needed to align revenue recognition for work completed but not billed, for the three and six months periods ended June 30, 2024 and June 30, 2023, were not material in any period.

v3.24.2
Subsequent Events
6 Months Ended
Jun. 30, 2024
Subsequent Events [Abstract]  
Subsequent Events

13. SUBSEQUENT EVENTS

There were no reportable events subsequent to June 30, 2024.
v3.24.2
New Accounting Standards (Policies)
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
New Accounting Standards

Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB’s Accounting Standards Codification (“ASC”).

 

Adoption of new accounting standards

None.

Accounting standards issued but not yet adopted

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures, which improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this update require that a public entity make additional disclosures related to segments if it has them. A public entity that has a single reportable segment would be required to provide all the disclosures required by the amendments in this update and all existing segment disclosures in Topic 280. The amendments in this update are affective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments in this update should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently assessing the impact that ASU 2023-07 will have on its financial statements and will adopt the amendments in this update upon the effective date.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures as well as improve the effectiveness of income tax disclosures. The amendments in this update require that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. The amendments in this update also require that all entities disclose on an annual basis certain detailed information about income taxes paid. The amendments in this update related to the rate reconciliation and income taxes paid disclosures improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. The amendments allow investors to better assess, in their capital allocation decisions, how an entity’s worldwide operations and related tax risks and tax planning and operational opportunities affect its income tax rate and prospects for future cash flows. The amendments in this update are affective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments in this update should be applied on a prospective basis. Retrospective application is permitted. The Company is currently assessing the impact that ASU 2023-09 will have on its financial statements and will adopt the amendments in this update prospectively upon the effective date.

In March 2024, the SEC adopted final rules requiring registrants to disclose climate-related information in their annual reports. The final rules require information about a registrant’s climate-related risks that have materially impacted, or are reasonably likely to have a material impact on, its business strategy, results of operations, or financial condition. In addition, under the final rules, certain disclosures related to severe weather events and other natural conditions will be required in a registrant’s audited financial statements. The new requirements are required on a prospective basis and a phased-in compliance period becomes effective for the Company beginning with its Annual Report on Form 10-K for the year ending December 31, 2025. However, pending the resolution of legal challenges that were subsequently filed against these rules, in April 2024, the SEC stayed the effectiveness of the rules. Therefore, the disclosure requirements of these rules and the timing of their effectiveness is uncertain. The Company is currently assessing the anticipated impact that the rules will have on its financial statements if and when effective and will implement disclosures upon any such effective dates.

Contingent Liabilities Autoliv’s warranty reserves are based upon the Company’s best estimates of amounts necessary to settle future and existing claims. The Company regularly evaluates the adequacy of these reserves and adjusts them when appropriate. However, the final amounts actually due related to these matters could differ materially from the Company’s recorded estimates.
v3.24.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
Derivative Financial Assets and Liabilities Measured at Fair Value on Recurring Basis

The tables below present information about the Company’s derivative financial assets and liabilities measured at fair value on a recurring basis (dollars in millions).

 

 

 

As of

 

 

 

 

June 30, 2024

 

 

 

December 31, 2023

 

 

 

 

 

 

 

Fair Value Measurements

 

 

 

 

 

 

Fair Value Measurements

 

 

Description

 

Nominal
volume

 

 

Derivative
asset
(Other
current assets)

 

 

Derivative
liability
(Other
current
liabilities)

 

 

 

Nominal
volume

 

 

Derivative
asset
(Other
current assets)

 

 

Derivative
liability
(Other
current
liabilities)

 

 

Derivatives not designated as hedging
   instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign exchange swaps, less
   than 6 months

 

$

2,166

 

1)

$

11

 

2)

$

15

 

3)

 

$

1,895

 

4)

$

22

 

5)

$

12

 

6)

Total derivatives not designated
   as hedging instruments

 

$

2,166

 

 

$

11

 

 

$

15

 

 

 

$

1,895

 

 

$

22

 

 

$

12

 

 

1) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $2,166 million.

2) Net amount after deducting for offsetting swaps under ISDA agreements is $11 million.

3) Net amount after deducting for offsetting swaps under ISDA agreements is $15 million.

4) Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,895 million.

5) Net amount after deducting for offsetting swaps under ISDA agreements is $22 million.

6) Net amount after deducting for offsetting swaps under ISDA agreements is $12 million.

Fair Value of Debt

The fair value and carrying value of debt is summarized in the table below (dollars in millions).

 

 

 

As of

 

 

 

June 30, 2024

 

 

December 31, 2023

 

 

 

Carrying
value
1)

 

 

Fair
value

 

 

Carrying
value
1)

 

 

Fair
value

 

Long-term debt

 

 

 

 

 

 

 

 

 

 

 

 

Bonds

 

$

1,540

 

 

$

1,525

 

 

$

1,023

 

 

$

1,022

 

Loans

 

 

 

 

 

 

 

 

301

 

 

 

306

 

Total long-term debt

 

 

1,540

 

 

 

1,525

 

 

 

1,324

 

 

 

1,328

 

 

 

 

 

 

 

 

 

 

 

 

 

Short-term debt

 

 

 

 

 

 

 

 

 

 

 

 

Short-term portion of long-term debt

 

 

282

 

 

 

285

 

 

 

297

 

 

 

297

 

Overdrafts and other short-term debt

 

 

174

 

 

 

174

 

 

 

241

 

 

 

241

 

Total short-term debt

 

$

455

 

 

$

459

 

 

$

538

 

 

$

538

 

1) Debt as reported in balance sheet.

v3.24.2
Inventories (Tables)
6 Months Ended
Jun. 30, 2024
Inventory Disclosure [Abstract]  
Components of Inventories

Inventories are stated at the lower of cost (“FIFO”) and net realizable value. The components of inventories were as follows (dollars in millions):

 

 

 

As of

 

 

 

June 30, 2024

 

 

December 31, 2023

 

Raw materials

 

$

422

 

 

$

457

 

Work in progress

 

 

324

 

 

 

347

 

Finished products

 

 

277

 

 

 

296

 

Inventories

 

 

1,023

 

 

 

1,100

 

Inventory valuation reserve

 

 

(87

)

 

 

(89

)

Total inventories, net of reserve

 

$

936

 

 

$

1,012

 

v3.24.2
Restructuring (Tables)
6 Months Ended
Jun. 30, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Change in Balance Sheet Position of Employee Related Restructuring Reserves

The table below summarizes the change in the balance sheet position of the employee-related restructuring reserves (dollars in millions). The restructuring reserve balances are included within Accrued expenses in the Condensed Consolidated Balance Sheets. The changes in the employee-related reserves have been charged against Other income (expense), net in the Consolidated Statements of Income. Restructuring costs other than employee related costs are immaterial for all periods presented.

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Reserve at beginning of the period

 

$

193

 

 

$

29

 

 

$

213

 

 

$

32

 

Provision - charge

 

 

13

 

 

 

107

 

 

 

14

 

 

 

110

 

Provision - reversal

 

 

(0

)

 

 

(0

)

 

 

(0

)

 

 

(0

)

Cash payments

 

 

(15

)

 

 

(9

)

 

 

(30

)

 

 

(15

)

Translation difference

 

 

(1

)

 

 

(0

)

 

 

(7

)

 

 

0

 

Reserve at end of the period

 

$

189

 

 

$

127

 

 

$

189

 

 

$

127

 

v3.24.2
Product-Related Liabilities (Tables)
6 Months Ended
Jun. 30, 2024
Product Warranties Disclosures [Abstract]  
Schedule of Change in Balance Sheet Position of Product-Related Liabilities

The table below summarizes the change in the balance sheet position of the product-related liabilities (dollars in millions). The reserve for product related liabilities is included in accrued expenses and other non-current liabilities on the Condensed Consolidated Balance Sheets. A majority of the Company’s product-related liabilities as of June 30, 2024 are covered by insurance. Insurance receivables are included within other current assets and other non-current assets on the Condensed Consolidated Balance Sheets. As of June 30, 2024, the Company had total insurance receivables of $57 million.

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Reserve at beginning of the period

 

$

78

 

 

$

141

 

 

$

96

 

 

$

145

 

Change in reserve

 

 

(1

)

 

 

42

 

 

 

(8

)

 

 

43

 

Cash payments

 

 

(4

)

 

 

(4

)

 

 

(14

)

 

 

(9

)

Translation difference

 

 

(0

)

 

 

(0

)

 

 

(1

)

 

 

(0

)

Reserve at end of the period

 

$

73

 

 

$

178

 

 

$

73

 

 

$

178

 

v3.24.2
Retirement Plans (Tables)
6 Months Ended
Jun. 30, 2024
Schedule of Components of Net Periodic Benefit Cost

The components of total Net Periodic Benefit Cost associated with the Company’s defined benefit retirement plans are as follows (dollars in millions):

 

U.S. Plans

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Interest cost

 

$

3

 

 

$

3

 

 

$

6

 

 

$

6

 

Expected return on plan assets

 

 

(3

)

 

 

(3

)

 

 

(6

)

 

 

(5

)

Settlement loss

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Net periodic benefit (gain) cost

 

$

(0

)

 

$

0

 

 

$

(0

)

 

$

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-U.S. Plans

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Service cost

 

$

2

 

 

$

3

 

 

$

5

 

 

$

5

 

Interest cost

 

 

3

 

 

 

3

 

 

 

6

 

 

 

5

 

Expected return on plan assets

 

 

(1

)

 

 

(0

)

 

 

(2

)

 

 

(1

)

Amortization of actuarial loss

 

 

0

 

 

 

0

 

 

 

1

 

 

 

0

 

Net periodic benefit cost

 

$

5

 

 

$

6

 

 

$

9

 

 

$

9

 

 

v3.24.2
Earnings per share (Tables)
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted EPS under Two-class Method

The computation of basic and diluted earnings per share is set forth in the table below. Anti-dilutive shares outstanding were immaterial for all periods presented below.

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

(In millions, except per share amounts)

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to controlling interest

 

$

138

 

 

$

53

 

 

$

265

 

 

$

127

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic: Weighted average common stock

 

 

80.9

 

 

 

85.6

 

 

 

81.6

 

 

 

85.9

 

Add: Weighted average stock options/share awards

 

 

0.2

 

 

 

0.1

 

 

 

0.4

 

 

 

0.2

 

Diluted weighted average common stock:

 

 

81.1

 

 

 

85.8

 

 

 

82.1

 

 

 

86.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings per share - basic

 

$

1.71

 

 

$

0.61

 

 

$

3.24

 

 

$

1.48

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings per share - diluted

 

$

1.71

 

 

$

0.61

 

 

$

3.23

 

 

$

1.47

 

v3.24.2
Revenue Disaggregation (Tables)
6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregated Revenue by Products and Region

The Company’s disaggregated revenue for the three and six months periods ended June 30, 2024 and June 30, 2023 were as follows (dollars in millions).

 

Net Sales by Products

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Airbags, Steering Wheels and Other1)

 

$

1,747

 

 

$

1,757

 

 

$

3,528

 

 

$

3,430

 

Seatbelt Products and Other1)

 

 

858

 

 

 

878

 

 

 

1,692

 

 

 

1,698

 

Total net sales

 

$

2,605

 

 

$

2,635

 

 

$

5,220

 

 

$

5,127

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Sales by Region

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Americas

 

$

893

 

 

$

916

 

 

$

1,786

 

 

$

1,747

 

Europe

 

 

761

 

 

 

751

 

 

 

1,531

 

 

 

1,476

 

China

 

 

468

 

 

 

497

 

 

 

928

 

 

 

950

 

Asia excl. China

 

 

483

 

 

 

471

 

 

 

975

 

 

 

954

 

Total net sales

 

$

2,605

 

 

$

2,635

 

 

$

5,220

 

 

$

5,127

 

1) Including Corporate sales.

v3.24.2
Basis of Presentation - Additional Information (Detail)
6 Months Ended
Jun. 30, 2024
Segment
Accounting Policies [Abstract]  
Number of reportable segments 1
v3.24.2
Fair Value Measurements - Additional Information (Detail)
€ in Millions, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 29, 2024
EUR (€)
Apr. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]              
Company Issued Eurobond | € € 500            
Interest expense     $ (28) $ (25) $ (54) $ (45)  
Coupon rate of notes 3.625%            
Company repaid private placement debt   $ 297          
Fair Value, Measurements, Nonrecurring              
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]              
Asset impairment charges     0 0 0 0  
Not Designated as Hedging Instrument              
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]              
Derivatives designated as hedging instruments     0   0   $ 0
Gains (losses) recognized in other non-operating items, net     (1) $ 13 10 $ 8  
Interest expense     $ 1   $ 2    
v3.24.2
Fair Value Measurements - Derivative Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Not Designated as Hedging Instrument - Fair Value, Measurements, Recurring - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Derivatives, Fair Value [Line Items]    
Nominal volume $ 2,166 $ 1,895
Derivative asset (Other current assets) 11 22
Derivative liability (Other current liabilities) 15 12
Less Than Six Months | Foreign Exchange Swaps    
Derivatives, Fair Value [Line Items]    
Nominal volume 2,166 [1] 1,895 [2]
Derivative asset (Other current assets) 11 [3] 22 [4]
Derivative liability (Other current liabilities) $ 15 [5] $ 12 [6]
[1] Net nominal amount after deducting for offsetting swaps under ISDA agreements is $2,166 million.
[2] Net nominal amount after deducting for offsetting swaps under ISDA agreements is $1,895 million.
[3] Net amount after deducting for offsetting swaps under ISDA agreements is $11 million.
[4] Net amount after deducting for offsetting swaps under ISDA agreements is $22 million.
[5] Net amount after deducting for offsetting swaps under ISDA agreements is $15 million.
[6] Net amount after deducting for offsetting swaps under ISDA agreements is $12 million.
v3.24.2
Fair Value Measurements - Derivative Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Parenthetical) (Detail) - Not Designated as Hedging Instrument - Foreign Exchange Swaps - Fair Value, Measurements, Recurring - Less Than Six Months - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Derivatives, Fair Value [Line Items]    
Derivative notional volume, amount after offsetting swaps $ 2,166 $ 1,895
Other current assets    
Derivatives, Fair Value [Line Items]    
Derivative asset, amount after offsetting swaps 11 22
Other current liabilities    
Derivatives, Fair Value [Line Items]    
Derivative liability, amount after offsetting swaps $ 15 $ 12
v3.24.2
Fair Value Measurements - Fair Value of Debt (Detail) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt [1] $ 1,540 $ 1,324
Short-term debt [1] 455 538
Long-term debt, fair value 1,525 1,328
Short-term debt, fair value 459 538
Bonds    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt [1] 1,540 1,023
Long-term debt, fair value 1,525 1,022
Loans    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Long-term debt [1] 0 301
Long-term debt, fair value 0 306
Short-Term Portion of Long-Term Debt    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term debt [1] 282 297
Short-term debt, fair value 285 297
Overdrafts and Other Short-Term Debt    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Short-term debt [1] 174 241
Short-term debt, fair value $ 174 $ 241
[1] Debt as reported in balance sheet.
v3.24.2
Income Taxes - Additional Information (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Taxes [Line Items]        
Effective income tax rate 24.10% 35.80% 25.50% 33.40%
Increase/(decrease) in effective tax rate due to impact of discrete tax items 4.90% 4.50% 3.70% 1.50%
Net increase to income tax reserves for unrecognized tax benefits based on tax positions related to current and prior years     $ 4  
Unrecognized tax benefits reserve that would impact effective tax rate if released into income $ 53   53  
Net Decrease To Income Tax Reserves For Unrecognized Tax Benefits Based on Tax Positions Related to Current and Prior Years     14  
Current Tax Payable Within Other Current Liabilities        
Income Taxes [Line Items]        
Unrecognized tax benefits reserve that would impact effective tax rate if released into income 16   16  
Non-Current Tax Payable Within Other Non-current Liabilities        
Income Taxes [Line Items]        
Unrecognized tax benefits reserve that would impact effective tax rate if released into income $ 37   $ 37  
v3.24.2
Inventories - Components of Inventories (Detail) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Raw materials $ 422 $ 457
Work in progress 324 347
Finished products 277 296
Inventories 1,023 1,100
Inventory valuation reserve (87) (89)
Total inventories, net of reserve $ 936 $ 1,012
v3.24.2
Restructuring - Additional Information (Detail)
$ in Millions
Jun. 30, 2024
USD ($)
Restructuring Cost and Reserve [Line Items]  
Restructuring reserve balance $ 189
v3.24.2
Restructuring - Schedule of Changes in Balance Sheet Position of Employee Related Restructuring Reserves (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Restructuring Cost and Reserve [Line Items]        
Reserve at end of the period $ 189   $ 189  
Restructuring employee-related        
Restructuring Cost and Reserve [Line Items]        
Reserve at beginning of the period 193 $ 29 213 $ 32
Provision - charge 13 107 14 110
Provision - reversal (0) (0) (0) (0)
Cash payments (15) (9) (30) (15)
Translation difference (1) 0 (7) 0
Reserve at end of the period $ 189 $ 127 $ 189 $ 127
v3.24.2
Product-Related Liabilities - Additional Information (Detail)
$ in Millions
Jun. 30, 2024
USD ($)
Product Warranty Liability [Line Items]  
Insurance receivables $ 57
v3.24.2
Product-Related Liabilities -Summary of Change in Balance Sheet Position of Product-Related Liabilities (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Product Warranties Disclosures [Abstract]        
Reserve at beginning of the period $ 78 $ 141 $ 96 $ 145
Change in reserve (1) 42 (8) 43
Cash payments (4) (4) (14) (9)
Translation difference 0 0 (1) 0
Reserve at end of the period $ 73 $ 178 $ 73 $ 178
v3.24.2
Retirement Plans - Components of Net Periodic Benefit Cost (Detail) - Pension Plans - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
U.S. Pension Plans        
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]        
Interest cost $ 3 $ 3 $ 6 $ 6
Expected return on plan assets (3) (3) (6) (5)
Settlement/curtailment gain 0 0 0 0
Net periodic benefit cost 0 0 0 1
Non-U.S. Pension Plans        
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]        
Service cost 2 3 5 5
Interest cost 3 3 6 5
Expected return on plan assets (1) 0 (2) (1)
Amortization of actuarial loss 0 0 1 0
Net periodic benefit cost $ 5 $ 6 $ 9 $ 9
v3.24.2
Retirement Plans - Additional Information (Details)
6 Months Ended
Jun. 30, 2024
Maximum [Member]  
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]  
Net periodic benefit cost 5.57%
Minimum [Member]  
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]  
Net periodic benefit cost 5.35%
Pension Plan [Member] | U.S. Pension Plans  
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]  
Expected long-term rate of return on assets 6.21%
v3.24.2
Contingent Liabilities - Additional Information (Detail)
Airbags in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2020
Vehicle
Jun. 30, 2024
USD ($)
Vehicle
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Sep. 05, 2023
Airbags
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Loss Contingencies [Line Items]                
Product liability insurance receivable   $ 73 $ 78 $ 96   $ 178 $ 141 $ 145
Insurance receivable related to recall   57            
Recall of frontal driver and passenger air bag | Airbags | Airbags         52      
Honda Buckle Recall | Damages from Product Defects                
Loss Contingencies [Line Items]                
Number of vehicles recalled | Vehicle 449,000              
Unannounced Recall | Damages from Product Defects                
Loss Contingencies [Line Items]                
Product liability insurance receivable   10            
ZF Inflator Recall | Maximum                
Loss Contingencies [Line Items]                
Estimate potential loss   43            
ZF Inflator Recall | Minimum                
Loss Contingencies [Line Items]                
Estimate potential loss   0            
ZF Inflator Recall | Damages from Product Defects                
Loss Contingencies [Line Items]                
Product liability insurance receivable   $ 0            
ZF Inflator Recall | Damages from Product Defects | Global                
Loss Contingencies [Line Items]                
Number of vehicles recalled | Vehicle   762,000            
v3.24.2
Stock Incentive Plan - Additional Information (Detail) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Share Based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares from treasury stock utilized by the Plan 16 20 117 112
Restricted Stock Units And Performance Stock Units        
Share Based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock compensation cost $ 4 $ 3 $ 8 $ 8
v3.24.2
Earnings Per Share - Schedule of Computation of Basic and Diluted EPS under Two-class Method (Detail) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Numerator:        
Net income attributable to controlling interest $ 138 $ 53 $ 265 $ 127
Denominator:        
Basic: Weighted average common stock 80.9 85.6 81.6 85.9
Add: Weighted average stock options/share awards 0.2 0.1 0.4 0.2
Diluted weighted average common stock: 81.1 85.8 82.1 86.0
Net earnings per share - basic $ 1.71 $ 0.61 $ 3.24 $ 1.48
Net earnings per share - diluted $ 1.71 $ 0.61 $ 3.23 $ 1.47
v3.24.2
Schedule of Disaggregated Revenue by Products and Region (Detail) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Disaggregation Of Revenue [Line Items]        
Net sales $ 2,605 $ 2,635 $ 5,220 $ 5,127
Airbags Steering Wheels and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Net sales [1] 1,747 1,757 3,528 3,430
Seatbelt Products and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Net sales [1] 858 878 1,692 1,698
China        
Disaggregation Of Revenue [Line Items]        
Net sales 468 497 928 950
Asia, excl. China        
Disaggregation Of Revenue [Line Items]        
Net sales 483 471 975 954
Americas        
Disaggregation Of Revenue [Line Items]        
Net sales 893 916 1,786 1,747
Europe        
Disaggregation Of Revenue [Line Items]        
Net sales $ 761 $ 751 $ 1,531 $ 1,476
[1] Including Corporate sales.